Sunday 24 June 2018

Covidien may sell drugs unit for $4bn

Covidien is looking to sell its pharmaceuticals unit for as much as $4 billion, a source familiar with the situation said on Tuesday. JPMorgan Chase is advising Covidien on the matter, said the source, who declined to be named because the


Covidien completes sale of sleep therapy products

Covidien, a leading provider of healthcare products, said it has completed the sale of its 'sleep therapy' continuous positive airway pressure (CPAP) and bi-level products to PH Invest, a privately held company located in Luxembourg.


Covidien completes tender offer for ev3 stake

Covidien, a Dublin-based global provider of healthcare products, has completed its tender offer to purchase all of the outstanding shares of common stock of ev3, a leading developer and marketer of endovascular devices. The tender offer wa

 1 2 3 4 5 >  Last ›

calendarCalendar of Events